News Detail

Dave and Buster's Reports Downbeat Q1 Earnings, Joins Alvotech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga · 06/16 12:05

Listen to the news

U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday.

Shares of Dave and Buster’s Entertainment, Inc (NASDAQ:PLAY) fell sharply in pre-market trading as the company reported downbeat earnings for the first quarter.

The company posted quarterly earnings of 22 cents per share, which missed the analyst consensus estimate of 61 cents per share. The company reported quarterly sales of $559.200 million, which missed the analyst consensus estimate of $580.461 million.

Dave and Buster’s shares dipped 13.4% to $10.67 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

Studio City International Hldg Ltd (NYSE:MSC) dipped 9.4% to $1.96 in pre-market trading.
Huntsman Corporation (NYSE:HUN) shares declined 8.8% to $14.50 in pre-market trading as the company and Olin agreed to merge.
Elevra Lithium Limited (NYSE:ELVR) dipped 8.3% to $93.80 in pre-market trading.
Alvotech SA (NASDAQ:ALVO) shares dipped 8% to $3.90 in pre-market trading after the company announced pricing of $152 million public offering of ordinary shares and concurrent private placement.
Cartesian Growth Corp III (NASDAQ:FAC) fell 8% to $14.30 in pre-market trading.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) fell 7.5% to $16.16 in pre-market trading as the company announced a $250 million convertible Senior Notes offering. The company also announced plans to separate its MRD and Immune Medicine businesses as it evaluates strategic and structural alternatives.
Akso Health Group – ADR (NASDAQ:AHG) declined 7% to $1.08 in pre-market trading after falling 13% on Monday.
Roma Green Finance Ltd (NASDAQ:ROMA) fell 6.7% to $7.15 in pre-market trading.
Prelude Therapeutics Inc (NASDAQ:PRLD) dipped 4.7% to $4.25 in pre-market trading.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.